Circular of the General Office of the Food and Drug Administration on the Follow-up of Suspected Group Adverse Incident of Perfluoropropane Gas for Ophthalmic Use Produced by Tianjin Jingming New Technology Development Co.
Information
Type
Regulatory / Normative Document
Regulated products
Medical Devices
Published
July 30, 2015
Last updated
July 30, 2015
Description
FGWJ-2015-10274
Tags
Organization
Country / Region
China
License
Other (Public Domain)